MKMagdalena Kowalczyk

Magdalena Kowalczyk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Magdalena Kowalczyk has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    DUAL BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE

    by Aleksandra Karnas, Gabriela Majka, Karol Bednarz, Piotr Pitrus, Anita Krowiak, Magdalena Kowalczyk, Karolina Krowiak, Anita Warzocha, Wiktoria Hander, Maria Jasiewicz

    Background: Inflammatory bowel diseases are increasingly common conditions occurring mainly in young people. The etiology of these diseases is not fully understood, so the treatment of choice is mainly conservative. The main target is to achieve and sustain clinical and endoscopic glucocorticosteroid-free remission. Purpose: The purpose of this study is to describe the non-standard use of dual biological therapy in selected groups of patients who have lost secondary response to treatment. Description: This article discusses two cases of patients suffering from ulcerative colitis and Crohn's disease. During standard therapy, disease exacerbations and secondary loss of response to biologic drugs were observed. The combination of two biologic drugs resulted in remission of the disease and improvement in the patient's clinical condition. Conclusions: Dual biologic therapy may show promise in the treatment of inflammatory bowel disease in selected groups of patients. Combining different mechanisms of action of drugs allows for comprehensive control of inflammation, increasing the effectiveness of treatment.

  • Open Access

    APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN IMAGING-BASED DIAGNOSIS OF ORTHOPEDIC INJURIES

    by Wiktoria Hander, Magdalena Kowalczyk, Piotr Pitrus, Anita Warzocha, Anita Krowiak, Gabriela Majka, Karolina Krowiak, Karol Bednarz, Maria Jasiewicz, Aleksandra Karnas

    Background and Objective: Medical imaging is fundamental in evaluating musculoskeletal injuries. The recent expansion of artificial intelligence (AI), especially in deep learning techniques, has led to new possibilities in image-based diagnostics. This review explores current AI-driven methods used in orthopedic trauma imaging and discusses their relevance in clinical settings. Scope of Review: The review encompasses studies from 2015 to 2025 that apply AI tools to the interpretation of X-rays, computed tomography (CT), and magnetic resonance imaging (MRI) in the context of fractures, ligament tears, and joint-related damage. It also includes predictive systems and decision-support technologies. Findings: AI solutions demonstrate notable performance in trauma detection, sometimes reaching diagnostic levels comparable to radiology experts. Deep neural networks are particularly effective in identifying soft tissue injuries in MRI, such as anterior cruciate ligament damage. Implementation is still hindered by insufficient clinical trials, data limitations, and the absence of universal methodological frameworks. Conclusions: AI applications in orthopedic imaging show strong promise. However, broader clinical adoption depends on further validation, methodological standardization, and effective integration into healthcare workflows.


  • Open Access

    SEMAGLUTIDE- REVOLUTIONARY DRUG IN OBESITY MANAGEMENT

    by Gabriela Majka, Karol Bednarz, Piotr Pitrus, Anita Krowiak, Magdalena Kowalczyk, Karolina Krowiak, Aleksandra Karnas, Anita Warzocha, Wiktoria Hander, Maria Jasiewicz

    Semaglutide is one of the most widely used glucagon-like peptide-1 receptor agonists, initially approved for the treatment of type 2 diabetes and now increasingly utilized for obesity treatment. Its efficacy in weight reduction has led to a surge in popularity; however, concerns regarding its safety profile and potential side effects have emerged. This review aims to analyze the mechanism of action, therapeutic efficacy, and potential risks associated with semaglutide use.

  • Open Access

    A COMPREHENSIVE REVIEW OF SURGICAL TREATMENTS FOR INGROWING TOENAILS

    by Magdalena Kowalczyk, Karol Bednarz, Piotr Pitrus, Anita Krowiak, Gabriela Majka, Karolina Krowiak, Anita Warzocha, Wiktoria Hander, Aleksandra Karnas, Maria Jasiewicz

    Ingrown toenails, also known as onychocryptosis, are a very common condition that affects patients' quality of life due to pain, inflammation, and the risk of infection. While conservative treatment is effective in mild cases, more severe or chronic forms of the condition usually require surgical intervention. Over the years, numerous surgical methods have been developed to improve treatment outcomes, reduce the risk of recurrence, and minimize postoperative complications. This review presents an evaluation of various surgical strategies, analyzing their effectiveness, advantages, disadvantages, and patient outcomes based on current clinical evidence. Ingrown Toenail Before Surgical Treatment: [Clinical Presentation from Private Collection]

  • Open Access

    ENHANCED RECOVERY AFTER SURGERY IN BARIATRIC SURGERY - REVIEW

    by Karol Bednarz, Anita Warzocha, Magdalena Kowalczyk, Piotr Pitrus, Anita Krowiak, Gabriela Majka, Karolina Krowiak, Wiktoria Hander, Aleksandra Karnas, Maria Jasiewicz

    Enhanced Recovery After Surgery (ERAS) is a multidisciplinary, evidence-based approach designed to optimize perioperative care, improve patient outcomes, and shorten hospital stays. This review examines the application of ERAS protocols in bariatric surgery—a critical intervention for the management of severe obesity and related comorbidities. Key components of ERAS in this context include preadmission counselling, minimized preoperative fasting, goal-directed fluid therapy, opioid-sparing anaesthesia techniques, and structured postoperative nutritional support. Current evidence indicates that adherence to ERAS protocols significantly reduces postoperative complications, accelerates recovery, and shortens the length of hospitalization. Moreover, ERAS has been associated with decreased incidence of postoperative nausea, improved pain control, and reduced reliance on opioids. The role of anaesthesiologists is pivotal in ERAS implementation, and standardized surgical techniques are essential for ensuring patient safety and consistency of care. Overall, this review highlights the growing importance of ERAS in bariatric surgery, emphasizing its effectiveness in enhancing both short- and long-term outcomes.

  • Open Access

    THE FUTURE OF ORTHOPAEDIC SURGERY: INTEGRATING 3D PRINTING, AI, AND BIOPRINTING

    by Karol Bednarz, Piotr Pitrus, Anita Krowiak, Gabriela Majka, Magdalena Kowalczyk, Karolina Krowiak, Anita Warzocha, Wiktoria Hander, Aleksandra Karnas, Maria Jasiewicz

    The integration of three-dimensional (3D) printing into orthopedic surgery has significantly influenced surgical planning, implant customization, and patient. outcomes. This review explores clinical applications and the future of 3D printing, bioprinting, artificial intelligence (AI), and future 4D printing technologies in orthopedics. The use of 3D-printed anatomical models and patient-specific surgical guides has been shown to reduce operative time, intraoperative blood loss, and radiation .exposure, while improving implant fit and. surgical precision. Custom-made implants offer individual solutions for reconstructions, especially in cases of severe bone loss and musculoskeletal oncology. Emerging innovations such as AI-assisted design and bioprinted scaffolds further enhance treatment strategies. Additionally, 4D printing.introduces smart implants capable of adapting to physiology, opening new possibilities orthopedic problems. Despite challenges related to cost and production time ongoing technological progress is paving the way for wider clinical adoption.

  • Open Access

    FROM BASEMENT MEMBRANE DEFECTS TO PRECISION MEDICINE: ADVANCES IN ALPORT SYNDROME

    by Karolina Krowiak, Anita Krowiak, Anita Warzocha, Piotr Pitrus, Karol Bednarz, Maria Jasiewicz, Gabriela Majka, Magdalena Kowalczyk, Wiktoria Hander, Aleksandra Karnas

    Alport syndrome is a hereditary disorder characterized by progressive renal dysfunction, sensorineural hearing loss, and ocular abnormalities, resulting from mutations in COL4A3, COL4A4, COL4A5. The clinical phenotype ranges from isolated hematuria to early-onset end-stage renal disease, with variability determined by inheritance patterns and specific genotypes. Diagnosis relies on combination of clinical assessment, renal biopsy with electron microscopy, and targeted genetic testing, enabling precise characterization of disease severity and informing management strategies. Current therapeutic approaches focus on renoprotective interventions, primarily angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, with emerging evidence supporting adjunctive use of sodium-glucose cotransporter 2 inhibitors. Novel experimental therapies, including endothelin receptor antagonists, glucagon-like peptide-1 receptor agonists, microRNA-targeted treatments, and gene or stem cell-based strategies, aim to address underlying molecular mechanism, though long-term safety and efficacy require further investigation. Advances in understanding genotype-phenotype correlations, combined with improvements in diagnostic workflows and therapeutic modalities, provide opportunities to slow disease progression, optimize clinical outcomes, and improve quality of life. This review summarizes current knowledge of AS, emphasizing clinical heterogeneity, diagnostic approaches, and evolving treatment paradigms.

  • Open Access

    MORE THEN A TRIAD: UNDERSTANDING THE COMPLEXITY OF PRUNE BELLY SYNDROME

    by Anita Krowiak, Karolina Krowiak, Anita Warzocha, Piotr Pitrus, Karol Bednarz, Maria Jasiewicz, Gabriela Majka, Magdalena Kowalczyk, Wiktoria Hander, Aleksandra Karnaś

    Aims: Prune Belly Syndrome (PBS), also known as Eagle-Barrett syndrome, is a rare congenital disorder defined by a triad of abdominal muscle deficiency, urinary tract anomalies and bilateral cryptorchidism. This review aims to summarize current knowledge on its etiology, clinical presentation and management. Methodology: This review was based on an extensive search of literature related to PBS using PubMed, Google Scholar and other scientific databases. Relevant clinical studies, reviews and case reports were analyzed to summarize current knowledge on diagnosis, management and outcomes of PBS. State of knowledge: PBS affects approximately 1 in 30,000 to 1 in 50,000 live births, with a strong male predominance. Its pathogenesis is thought to be multifactorial, involving mesodermal maldevelopment and possible genetic factors. The clinical spectrum ranges from severe cases with renal dysplasia and pulmonary hypoplasia to a milder, incomplete form. Woodard’s classification is commonly used to guide prognosis and treatment. Besides the classic triad, patients may present with gastrointestinal, musculoskeletal, cardiopulmonary and developmental systems. Early prenatal diagnosis is possible through imaging. Postnatal care includes urologic reconstruction, orchiopexy, abdominoplasty, renal support and in some cases, transplantation. Assisted reproductive techniques have allowed for fertility in select male patients. Conclusion: PBS is a complex and variable condition requiring early diagnosis and individualized, multidisciplinary care. Advances in surgical and medical treatment have improved outcomes, but long-term monitoring and supportive care remain essential for preserving function and quality of life.

  • Open Access

    Polymyalgia rheumatica - risk factors, pathogenesis, diagnostic methods, treatment - new literature reports

    by Anita Warzocha, Anita Krowiak, Gabriela Majka, Piotr Pitrus, Karolina Krowiak, Magdalena Kowalczyk, Karol Bednarz, Maria Jasiewicz, Wiktoria Hander, Aleksandra Karnas

    Introduction and Aim Polymyalgia rheumatica (PMR) is a systemic inflammatory disease predominantly affecting individuals over the age of 50, with a higher incidence among women. It is characterized by pain and stiffness in the shoulder and hip girdles, often accompanied by systemic symptoms such as fatigue, low-grade fever, and weight loss. The aim of this paper is to present a review of the current literature concerning risk factors, pathogenesis, diagnostic methods, and therapeutic options in PMR, with particular attention to recent scientific findings. Brief Description of Current Knowledge Although the etiology of PMR has not been fully elucidated, genetic predisposition, environmental influences, and age-related immune dysfunction are considered significant contributors. The disease often coexists with giant cell arteritis (GCA), complicating diagnosis. Glucocorticosteroids remain the cornerstone of therapy; however, recent studies emphasize the growing role of steroid-sparing agents and biologic therapies such as sarilumab and tocilizumab. Advances in imaging modalities and biomarker identification have enhanced diagnostic accuracy and facilitated earlier intervention. Summary Polymyalgia rheumatica continues to pose diagnostic and therapeutic challenges, particularly in patients with atypical presentations or treatment resistance. Individualized therapeutic approaches are essential to optimize outcomes. Further research is warranted to clarify the underlying pathogenesis and to refine management strategies, aiming to improve long-term prognosis and reduce treatment-associated complications.